The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer.
Tanguy Y. Seiwert
Consultant or Advisory Role - Novartis; Onyx
Research Funding - Boehringer Ingelheim; Genentech
Barbara Burtness
No relevant relationships to disclose
Jared Weiss
No relevant relationships to disclose
Iris Gluck
No relevant relationships to disclose
Joseph Paul Eder
No relevant relationships to disclose
Sara I Pai
Consultant or Advisory Role - Merck (U)
Marisa Dolled-Filhart
Employment or Leadership Position - Merck
Kenneth Emancipator
Employment or Leadership Position - Merck
Kumudu Pathiraja
Employment or Leadership Position - Merck
Christine Gause
Employment or Leadership Position - Merck
Robert Iannone
Employment or Leadership Position - Merck
Stock Ownership - Merck
Holly Brown
Employment or Leadership Position - Merck
Jennifer Houp
Employment or Leadership Position - Merck
Jonathan D. Cheng
Employment or Leadership Position - Merck
Stock Ownership - Merck
Research Funding - Merck
Laura Quan Man Chow
No relevant relationships to disclose